EZM0414

Item number	Size	Delivery time	Price
TGM-T9969-1mg	1 mg	7 - 10 business days*	263.00€
TGM-T9969-5mg	5 mg	7 - 10 business days*	651.00€
TGM-T9969-10mg	10 mg	7 - 10 business days*	926.00€
TGM-T9969-25mg	25 mg	7 - 10 business days*	1,383.00€
TGM-T9969-50mg	50 mg	7 - 10 business days*	1,858.00€
TGM-T9969-100mg	100 mg	7 - 10 business days*	2,513.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: EZM0414 is a potent and selective, orally bioavailable inhibitor of SETD2 with an... more

Close menu

Product information "EZM0414"

Description: EZM0414 is a potent and selective, orally bioavailable inhibitor of SETD2 with an IC50 of 18 nM in biochemical assays and 34 nM in cellular assays, potentially useful for researching relapsed or refractory multiple myeloma and diffuse large B-cell lymphoma [1]. Target: Histone Methyltransferase. Smiles: [H][C@@]1(CCC[C@H](C1)NC(=O)c1cc2c(F)ccc(C)c2[nH]1)N1CCN(CC1)C(C)=O. References: Jennifer Totman, et al. Pharmacologic Inhibition of the Histone Methyltransferase SETD2 with EZM0414 As a Novel Therapeutic Strategy in Relapsed or Refractory Multiple Myeloma and Diffuse Large B-cell Lymphoma.

Supplier:	TargetMol
Supplier-Nr:	T9969

Properties

MW:	400.49 D
Formula:	C22H29FN4O2

Database Information

CAS :

2411748-50-8| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+20°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "EZM0414"

Write a review